Cargando…

Propranolol and breast cancer—a work in progress

The non-selective beta-blocker propranolol is a leading candidate for repurposing as a novel anti-cancer agent. Emerging evidence, including human data, suggests that there are multiple mechanisms of action particularly relevant to breast cancer. This editorial reviews a number of recent studies tha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pantziarka, Pan, Bryan, Brad A, Crispino, Sergio, Dickerson, Erin B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cancer Intelligence 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027968/ https://www.ncbi.nlm.nih.gov/pubmed/30034523 http://dx.doi.org/10.3332/ecancer.2018.ed82

Ejemplares similares

Does the oncology community have a rejection bias when it comes to repurposed drugs?
por: Gyawali, Bishal, et al.
Publicado: (2018)

The beta adrenergic receptor antagonist propranolol alters mitogenic and apoptotic signaling in late stage breast cancer
por: Montoya, Alexa, et al.
Publicado: (2019)

Repurposing of drugs for triple negative breast cancer: an overview
por: Spini, Andrea, et al.
Publicado: (2020)

Repurposing Drugs in Oncology (ReDO)—Propranolol as an anti-cancer agent
por: Pantziarka, Pan, et al.
Publicado: (2016)

Propranolol Sensitizes Vascular Sarcoma Cells to Doxorubicin by Altering Lysosomal Drug Sequestration and Drug Efflux
por: Saha, Jhuma, et al.
Publicado: (2021)

Recycling existing drugs for cancer therapy: delivering low cost cancer care
por: Pantziarka, Pan, et al.
Publicado: (2014)

Repurposing drugs in oncology (ReDO)—selective PDE5 inhibitors as anti-cancer agents
por: Pantziarka, Pan, et al.
Publicado: (2018)

Metformin and propranolol combination prevents cancer progression and metastasis in different breast cancer models
por: Rico, María, et al.
Publicado: (2016)

Regression of primary cardiac angiosarcoma and metastatic nodules following propranolol as a single agent treatment
por: Galván, Dana C., et al.
Publicado: (2018)

Beta Adrenergic Signaling: A Targetable Regulator of Angiosarcoma and Hemangiosarcoma
por: Dickerson, Erin B., et al.
Publicado: (2015)

Correction: Regression of primary cardiac angiosarcoma and metastatic nodules following propranolol as a single agent treatment
por: Galván, Dana C., et al.
Publicado: (2019)

The wisdom of crowds and the repurposing of artesunate as an anticancer drug
por: Augustin, Yolanda, et al.
Publicado: (2015)

Understanding the impact of breast cancer adjuvant endocrine therapy on cognitive function: a work in progress
por: Ganz, Patricia A
Publicado: (2016)

Propranolol treatment of infantile hemangioma endothelial cells: A molecular analysis
por: STILES, JESSICA, et al.
Publicado: (2012)

Pulsatile tinnitus: treatment with clonazepam and propranolol
por: Albertino, Sergio, et al.
Publicado: (2015)

Propranolol and survival from breast cancer: a pooled analysis of European breast cancer cohorts
por: Cardwell, Chris R., et al.
Publicado: (2016)

Repositioning metformin and propranolol for colorectal and triple negative breast cancers treatment
por: Anselmino, L. E., et al.
Publicado: (2021)

Propranolol sensitizes prostate cancer cells to glucose metabolism inhibition and prevents cancer progression
por: Brohée, Laura, et al.
Publicado: (2018)

Primed for cancer: Li Fraumeni Syndrome and the pre-cancerous niche
por: Pantziarka, Pan
Publicado: (2015)

Li Fraumeni syndrome, cancer and senescence: a new hypothesis
por: Pantziarka, Pan
Publicado: (2013)

Role of propranolol in hemangiomas
por: Gajbhiye, Vishal, et al.
Publicado: (2011)

Propranolol for Infantile Hemangiomas
por: Levy, Moise L.
Publicado: (2012)

Agonist Effects of Propranolol on Non-Tumor Human Breast Cells
por: Gargiulo, Lucía, et al.
Publicado: (2020)

Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension
por: Kim, Jae Hyun, et al.
Publicado: (2014)

Reciprocity in breast cancer progression
por: Gespach, Christian
Publicado: (2014)

Subglottic Hemangioma Treated With Propranolol
por: Hardison, Scott A., et al.
Publicado: (2014)

EFFICACY OF PROPRANOLOL ON SCHIZOPHRENIC THOUGHT DISORDER
por: Sethi, B. B., et al.
Publicado: (1981)

Potential effect of chloroquine and propranolol combination to treat colorectal and triple-negative breast cancers
por: Anselmino, L. E., et al.
Publicado: (2023)

Paediatric pathology: a work in progress
por: Peres, Luiz Cesar
Publicado: (2014)

The role of propranolol as a radiosensitizer in gastric cancer treatment
por: Liao, Xinhua, et al.
Publicado: (2018)

Propranolol for the treatment of vascular sarcomas
por: Wagner, Michael J, et al.
Publicado: (2018)

Propranolol for treatment of infantile hemangiomas
por: de Melo, Juliana Nakano, et al.
Publicado: (2013)

Trichodynia Silenced Effectively with Propranolol
por: Brzezinski, Piotr, et al.
Publicado: (2019)

Propafenone and propranolol dual toxicity
por: Farooq, Moonis, et al.
Publicado: (2020)

Propranolol in the Treatment of Infantile Hemangiomas
por: Tan, Xin, et al.
Publicado: (2021)

Inhibiting the Priming for Cancer in Li-Fraumeni Syndrome
por: Pantziarka, Pan, et al.
Publicado: (2022)

The diagnostic–clinical chasm: Work in progress?
por: Nkengasong, John N.
Publicado: (2016)

Global Access to Radiotherapy—Work in Progress
por: Gospodarowicz, Mary
Publicado: (2021)

Mechanisms of propranolol action in infantile hemangioma
por: Kum, Jina JY, et al.
Publicado: (2015)

Emergent properties of a computational model of tumour growth
por: Pantziarka, Pan
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pi1282rianvspnh6j49o2pcqbi